Viewing StudyNCT00023166



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00023166
Status: TERMINATED
Last Update Posted: 2005-06-24
First Post: 2001-08-24

Brief Title: Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors Lymphomas
Sponsor: Enzon Pharmaceuticals Inc
Organization: Enzon Pharmaceuticals Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-05
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2002-05
Completion Date Type: None
First Submit Date: 2001-08-24
First Submit QC Date: August 25 2001
Study First Post Date: 2001-08-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2005-06-23
Last Update Post Date: 2005-06-24
Last Update Post Date Type: ESTIMATED